FDA Seeks to Probe Talks between Nassau oTB & teamsters loca 707 regarding job promotion process Between Staff and Biogen on Alzheimer’s Drug
The Food and Drug Administration’s chief is taking the highly unusual step of asking for a federal investigation of doctors within her own agency
A Biogen facility in Cambridge, Mass.
PHOTO: BRIAN SNYDER/REUTERS
The Food and Drug Administration’s acting commissioner, Janet Woodcock, is taking the highly unusual step of asking for a federal investigation of doctors within her own agency who met with the makers of an Alzheimer’s drug before the medicine’s recent approval.
Dr. Woodcock, in a letter made public Friday, called for the Office of Inspector General of the Department of Health and Human Services, which oversees the FDA, to review interactions between the drugmaker and FDA staff during the approval process.
The...
No comments:
Post a Comment